| Nintedanib for systemic sclerosis–associated interstitial lung disease O Distler, KB Highland, M Gahlemann, A Azuma, A Fischer, MD Mayes, ... New England Journal of Medicine 380 (26), 2518-2528, 2019 | 1515 | 2019 |
| Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial DP Tashkin, MD Roth, PJ Clements, DE Furst, D Khanna, EC Kleerup, ... The lancet Respiratory medicine 4 (9), 708-719, 2016 | 1079 | 2016 |
| Systemic sclerosis-associated interstitial lung disease A Perelas, RM Silver, AV Arrossi, KB Highland The Lancet respiratory medicine 8 (3), 304-320, 2020 | 382 | 2020 |
| Long-Term Effects of Inhaled Corticosteroids on FEV1 in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis KB Highland, C Strange, JE Heffner Annals of internal medicine 138 (12), 969-973, 2003 | 220 | 2003 |
| Clinical profile of anti-PL-12 autoantibody: cohort study and review of the literature M Kalluri, SA Sahn, CV Oddis, SL Gharib, L Christopher-Stine, SK Danoff, ... Chest 135 (6), 1550-1556, 2009 | 208 | 2009 |
| Interstitial lung disease in the patient who has connective tissue disease C Strange, KB Highland Clinics in chest medicine 25 (3), 549-559, 2004 | 193 | 2004 |
| Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial KB Highland, O Distler, M Kuwana, Y Allanore, S Assassi, A Azuma, ... The Lancet Respiratory Medicine 9 (1), 96-106, 2021 | 184 | 2021 |
| Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma MC Garin, KB Highland, RM Silver, C Strange The Journal of Rheumatology 36 (2), 330-336, 2009 | 158 | 2009 |
| Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival RL Benza, RJ Barst, N Galie, A Frost, RE Girgis, KB Highland, C Strange, ... Chest 134 (4), 775-782, 2008 | 149 | 2008 |
| Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials LA Saketkoo, S Mittoo, D Huscher, D Khanna, PF Dellaripa, O Distler, ... Thorax 69 (5), 436-444, 2014 | 148 | 2014 |
| Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled … JJ Solomon, SK Danoff, FA Woodhead, S Hurwitz, R Maurer, I Glaspole, ... The Lancet Respiratory Medicine 11 (1), 87-96, 2023 | 134 | 2023 |
| Lymphocytic interstitial pneumonia TS Panchabhai, C Farver, KB Highland Clinics in Chest Medicine 37 (3), 463-474, 2016 | 117 | 2016 |
| Pulmonary involvement in Sjögren syndrome M Kreider, K Highland Seminars in respiratory and critical care medicine 35 (02), 255-264, 2014 | 116 | 2014 |
| Pulmonary involvement in Sjögren syndrome M Kokosi, EC Riemer, KB Highland Clinics in chest medicine 31 (3), 489-500, 2010 | 110 | 2010 |
| Ambrisentan for sarcoidosis associated pulmonary hypertension MA Judson, KB Highland, S Kwon, JF Donohue, R Aris, N Craft, S Burt, ... Sarcoidosis Vasc Diffuse Lung Dis 28 (2), 139-145, 2011 | 99 | 2011 |
| New developments in scleroderma interstitial lung disease KB Highland, RM Silver Current opinion in rheumatology 17 (6), 737-745, 2005 | 98 | 2005 |
| Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial S Farha, D Saygin, MM Park, HI Cheong, K Asosingh, SAA Comhair, ... JCI insight 2 (16), 2017 | 97 | 2017 |
| Pulmonary hypertension in interstitial lung disease C Strange, KB Highland Current opinion in pulmonary medicine 11 (5), 452-455, 2005 | 79 | 2005 |
| Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature O Kowal-Bielecka, K Kowal, KB Highland, RM Silver Seminars in arthritis and rheumatism 40 (1), 73-88, 2010 | 78 | 2010 |
| Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline G Raghu, SB Montesi, RM Silver, T Hossain, M Macrea, D Herman, ... American Journal of Respiratory and Critical Care Medicine, 2023 | 77 | 2023 |
